The Effects of Robots on Children with Autism Spectrum Disorder: A Meta-analysis.

J Autism Dev DisordMay 21, 2025 (epub)
Clinical ResearchPediatricsPsychiatryOpen access

Weihao Wang, Jian Xiao, Long Diao

✦ AI-curated · Sources linked

In 30 seconds

This meta-analysis assessed robotic interventions intended to support development in children with autism spectrum disorder (ASD). It included 14 studies published between 2015 and 2024, representing 408 children and 58 independent effect sizes, and used a random-effects model. The pooled effect was d = 0.829 (95% CI = [0.657, 1.000]), which the authors characterized as large. Effects varied by robot role, developmental domain, region, study design, and use of control groups. Greater teacher involvement and longer instructional sessions were associated with stronger intervention effects.

Key findings

  • Across 14 studies and 408 children with ASD, the pooled effect was d = 0.829 (95% CI = [0.657, 1.000]).
  • Effect sizes varied according to robot function, developmental domain, geographical region, experimental design, and inclusion of control groups.
  • Effect sizes decreased as teacher involvement diminished.
  • Longer instructional session durations were positively associated with intervention effectiveness in meta-regression.

Why it matters

The findings suggest that robotic interventions may support development in children with ASD, while also indicating that outcomes depend on how interventions are delivered and evaluated. Teacher participation and session duration may be relevant when designing or interpreting these programs. The observed variability underscores the need to consider intervention context rather than treating robotic approaches as a uniform intervention.

What to keep in mind

The meta-analysis included 14 studies, and the abstract reports substantial variability in effect sizes across study and intervention characteristics.

Source

Published in J Autism Dev Disord. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.